| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/05/2004 | US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent |
| 10/05/2004 | US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 10/05/2004 | US6800441 Heparanase specific molecular probes and their use in research and medical applications |
| 10/05/2004 | US6800317 Phytosterol compositions |
| 10/05/2004 | US6800290 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 10/05/2004 | US6800285 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 10/05/2004 | CA2264243C Glp-1 derivatives |
| 10/02/2004 | CA2462999A1 Implantable pouch seeded with insulin-producing cells to treat diabetes |
| 09/30/2004 | WO2004083380A2 Methods and compositions for modulating glycogen synthesis and breakdown |
| 09/30/2004 | WO2004083231A2 Use of peptide ligands for plasma membrane receptors or similar for mitochondrial activity modulation |
| 09/30/2004 | WO2004083220A1 Optically detectable (alkylacyl-2-aminodesoxy-glycero)-nitrophenyl-phosphonates |
| 09/30/2004 | WO2004083211A1 Pyrazolopyrimidine compound and use thereof |
| 09/30/2004 | WO2004083209A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083203A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | WO2004083199A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083198A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083184A1 Receptor antagonist |
| 09/30/2004 | WO2004083179A1 Remedy for diabetes |
| 09/30/2004 | WO2004083167A1 Sulfamide derivative and medicinal composition thereof |
| 09/30/2004 | WO2004082702A1 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 09/30/2004 | WO2004082700A1 Composition for treatment and prevention of obesity and adult disease |
| 09/30/2004 | WO2004082680A1 Pramipexole for reducing excessive food intake by children |
| 09/30/2004 | WO2004082667A1 Treatment of type 1 diabetes with pde5 inhibitors |
| 09/30/2004 | WO2004082574A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 09/30/2004 | WO2004069781A3 7-(3,5-diisopropylphenyl) heptatrienoic acid derivatives having serum glucose reducing activity |
| 09/30/2004 | WO2004058268A3 Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders |
| 09/30/2004 | WO2004046355A3 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 09/30/2004 | WO2004032716A3 Compounds for modulation of cholesterol transport |
| 09/30/2004 | WO2003087333A8 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 09/30/2004 | WO2003068197A8 Method for systemic drug delivery through the nail |
| 09/30/2004 | US20040194159 Cloning pigs using donor nuclei from differentiated cells |
| 09/30/2004 | US20040192943 Nf-kappab inhibitors |
| 09/30/2004 | US20040192914 Compounds and methods |
| 09/30/2004 | US20040192908 Human and veterinary medicine; drugs, cosmetics ; prevention therapy dyslipidemia; cardiovascular disorders; antidiabetic agents; obesity; hypotensive agents; antiaging agents; anticancer agents |
| 09/30/2004 | US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents |
| 09/30/2004 | US20040192784 Synergistic mixture; containing hydroxy-3-methylglutaryl/3-/ coenzyme a inhibitor |
| 09/30/2004 | US20040192774 Method for improving the well-being of poultry by in-ovo injection of carnitine |
| 09/30/2004 | US20040192766 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192765 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192764 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease |
| 09/30/2004 | US20040192736 New indoline compounds |
| 09/30/2004 | US20040192716 Mixture with 2-amino-1,3-propanediol and excipients; synergistic mixture; concurrent administering |
| 09/30/2004 | US20040192711 Kinase inhibitor; therapy for leukemia, lymphoma; skin cancer; autoimmune diseases; antiinflammatory agents; sunscreen agents |
| 09/30/2004 | US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents |
| 09/30/2004 | US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 09/30/2004 | US20040192682 1,5-Dihydro-pyrazolo[4,3-c]pyridazin-6-one derivatives; glycogen synthase kinase-3 (CSK) inhibitors; nervous system, psychological, and neurodegenerative disorders; diabetes, psychiatry, multiple sclerosis (MS), myocardial infarction, reperfusion/ischemia, alopecia, and stroke |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | US20040192671 Benzo[d]azepine derivatives as 5-ht6 receptor anatagonists |
| 09/30/2004 | US20040192670 For inhibiting bone resorption, treating/preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, aniogenesis, atherosclerosis, arthritis, tumor growth and metastasis |
| 09/30/2004 | US20040192667 Novel pyrazole analogs acting on cannabinoid receptors |
| 09/30/2004 | US20040192608 Treatment of obesity |
| 09/30/2004 | US20040192607 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 09/30/2004 | US20040192606 treating an infection or ischemic wound in a mammal by administering relaxin; treating ischemic ulcer with recombinant human relaxin (H2) for example |
| 09/30/2004 | US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/30/2004 | US20040191926 Ptp1b inhibitors and ligands |
| 09/30/2004 | US20040191901 Insulin producing cells derived from human embryonic stem cells |
| 09/30/2004 | US20040191800 Comprises nucleotide sequences coding protein which controls thermogenesis in human skeletal muscle and heart for prevention and treatment of obesity, cachexia, cardiovascular and muscular disorders |
| 09/30/2004 | US20040191242 Method for producing a vaccine |
| 09/30/2004 | US20040191212 Phosphate-binding polymers for oral administration |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | US20040191209 Drugs for ameliorating postcibal hyperglycemia |
| 09/30/2004 | DE10312809A1 Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern Pramipexole to reduce excessive food intake in children |
| 09/30/2004 | CA2522176A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | CA2519584A1 Pramipexole for reducing excessive food intake by children |
| 09/30/2004 | CA2519444A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519442A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519440A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519372A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519357A1 Treatment of type 1 diabetes with pde5 inhibitors |
| 09/30/2004 | CA2519250A1 Therapeutic agent for diabetes mellitus |
| 09/30/2004 | CA2517191A1 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 09/29/2004 | EP1462518A1 Adipocyte differentiation-associated gene and protein |
| 09/29/2004 | EP1462439A1 Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same |
| 09/29/2004 | EP1462096A1 Methods and compositions for pulmonary delivery of insulin |
| 09/29/2004 | EP1461446A2 Lipid-associated molecules |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461440A2 Cultured cells from pancreatic islets |
| 09/29/2004 | EP1461421A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461351A2 Methods and reagents for diagnosis and treatment of diabetes |
| 09/29/2004 | EP1461347A1 2-o-(-d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 09/29/2004 | EP1461339A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/29/2004 | EP1461337A1 Pyrido[2,1-a]isoquinoline derivatives as dpp-iv inhibitors |
| 09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
| 09/29/2004 | EP1461333A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461323A2 Compounds for the treatment of metabolic disorders |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1461165A1 Metallic structures incorporating bioactive materials and methods for creating the same |
| 09/29/2004 | EP1461070A2 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 09/29/2004 | EP1461069A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia |
| 09/29/2004 | EP1461068A1 Methods of compositions for normalizing lipid levels in mammalian tissues |
| 09/29/2004 | EP1461054A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 09/29/2004 | EP1461051A1 Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors |
| 09/29/2004 | EP1461044A1 Pharmaceutical compositions comprising active vitamin d compounds |
| 09/29/2004 | EP1461040A1 Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof |